系统的可用药物全基因组门德尔随机化确定了儿童喘的治疗点
Junjie Bi1, Xue Liu2, Jingjing Zhang3
1Department of Gerontology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
Medicine
|December 16, 2025
概括
门德尔的随机化确定了35个与儿童喘相关的可用药物的基因. BLVRA显示出作为开发儿童喘新疗法的治疗点的潜力.
科学领域:
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
- 儿科 儿科 儿科
背景情况:
- 儿童喘管理和预防面临着持续的挑战.
- 门德尔随机化 (MR) 是一种用于发现新的治疗点的强大方法.
- 识别可用药的点对于有效的喘治疗至关重要.
研究的目的:
- 进行全基因组MR分析,以找到可用药物治疗儿童喘的治疗点.
- 探索药物向基因与儿童喘发育之间的因果关系.
- 引导开发更有效,更精确的喘治疗方法.
主要方法:
- 综合基因组数据可用于药物标,表达定量特征位置 (eQTL) 和儿童喘的GWAS.
- 应用孟德尔随机化 (MR) 来调查因果关系.
- 利用反向MR,局部化,丰富分析,蛋白相互作用网络,药物预测和分子对接进行验证.
主要成果:
- 确定了35个可用药物的基因,与儿童喘有显著的关联.
- 强调BLVRA作为一个特别有前途的治疗点.
- 在这些基因中,BLVRA,SLC9A3,LYZ,SRPK1,HOXA5,LYVE1,S100A9,ADORA1,RPL13,IL7R,SLFN11,SHMT1,CLN8,TOP1MT,LPAR5,RNASET2,ANK1,H6PD,DSP,CDC25B,VWF,ITK,CACNG6,ITGB7,S100A8,ADAM12,ST14,BMP6,HK2,SYK,ABCA1,ULK4,KBTBD2,SLCO4C1是被发现的基因之一.
结论:
- BLVRA成为儿童喘治疗的潜在关键目标.
- 这项研究有助于优先考虑儿童喘药物开发工作.
- 这些发现为儿童喘护理中新的治疗策略提供了基础.
更多相关视频
05:53Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
10.5K
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.6K
相关概念视频
01:19Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:20Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
01:26Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
01:30Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
01:29Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K